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 Summary
 Background: Application of intravoxel incoherent motion (IVIM) model parameters, including: true diffusion (D), 
pseudodiffusion (D*), and perfusion fraction (Fp), for differentiation between metastatic and non-
metastatic head and neck lymph nodes.
 Material/Methods: Diffusion-weighted images/apparent diffusion coefficient (DWI/ADC) images of 86 lymph nodes 
from 31 cancer patients were analyzed. DWI images were obtained with a 1.5T MRI scanner 
(Magnetom Avanto); b=0,50, 150, 300, 500, 750, 1000, 1200 s/mm2.
 Results: In the study group, there were 32 (37%) and 54 (67%) metastatic and non-metastatic lymph nodes, 
respectively. The mean values of D, D*, and Fp did not differ significantly between metastatic and 
non-metastatic lymph nodes.
 Conclusions: IVIM parameters are not useful for differentiation between metastatic and non-metastatic head 
and neck lymph nodes.
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A precise determination of nodal involvement is important 
for staging and critical for optimal planning of treatment 
in patients with head and neck carcinoma (HNC). The dif-
ferentiation between normal (non-metastatic) and meta-
static lymph nodes (especially when not enlarged), based 
only on palpation, is usually difficult, and it is often not 
possible at all in some nodal localizations. Considering the 
shape and dimensions of lymph nodes, standard MRI or CT 
scans do not always distinguish between metastatic and 
normal lymph nodes. Currently, new noninvasive meth-
ods are needed for an accurate characterization of both 
primary tumors of the head and neck and nodal metasta-
ses. This characterization is critical for planning individu-
alized treatment and for improved management of cancer 
patients. Diffusion-weighted imaging (DWI) is a new tech-
nique that may help to detect metastatic lymph nodes and 
differentiate them from non-metastatic lymph nodes.
Intravoxel incoherent motion (IVIM), initially described by 
Le Bihan et al. [1], is an advanced imaging technique that 
separates diffusion and perfusion by calculating several 
diffusion- and perfusion-related parameters. In DWI, tissue 
signal attenuation that is observed with increasing b val-
ues, reflects tissue diffusivity, which reduces the effect of 
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tissue microcapillary perfusion. This signal attenuation can 
be measured quantitatively. The most common quantitative 
evaluation of DWI is provided by the apparent diffusion 
coefficient (ADC). ADC values are influenced by both tissue 
diffusivity and pseudorandom motion caused by microcap-
illary perfusion, also known as pseudodiffusion.
It has been generally accepted that microperfusion affects 
signal values measured with low values of the b coeffi-
cient [1–3]. Optimal b threshold values, between the true 
diffusion (D), pseudodiffusion (D*), and perfusion fraction 
(Fp), have not been unequivocally determined to date; 
b=200 s/mm2 has been reported most commonly [2,4–8]. 
In this study, we attempted to differentiate between meta-
static and normal lymph nodes, based on the values of D*, 
Fp, and D.
Material and Methods
MRI scans of 86 neck lymph nodes, obtained from 31 can-
cer patients, were analyzed. In all lymph nodes, a diag-
nosis was confirmed by a histopathological or cytological 
examination. Almost all patients (29/31, 93.5%) had HNC, 
and MRI was performed for staging before treatment. 
In 2 (6.5%) patients from this group, metastases from an 
unknown primary source were diagnosed. In this study 
group, there were 49% of men and 51% of women; the 
mean age was 58 years (range: 25–71 years); most patients 
were had 61–70 years. Among a total of 86 lymph nodes, 
there were 32 (37%) metastatic and 54 (67%) non-metastatic 
nodes, respectively. All MRI scans were performed in the 
Radiodiagnostic Department of the Center of Oncology, 
Institute Maria Skłodowska-Curie Memorial, Gliwice 
branch, Poland.
A 1.5T MRI scanner (Magnetom Avanto, Siemens, Erlangen, 
Germany), with a head and neck coil was used to obtain all 
MR images. The standard MRI protocol for head and neck 
lesions (used in our institution for HNC) was applied.
Algorithms that were used are presented in Table 1.
Macroscopic descriptions of surgical specimens were used 
for confirmation of the topography of resected lymph nodes 
that had been revealed on MRI. Subsequently, dimen-
sions and distances from characteristic anatomical struc-
tures (parotid glands, mandibular glands, and MSO) were 
assessed.
D*, D, and Fp were calculated according to the equation 
proposed by Le Bihan in the IVIM model [2,6,9,10].
As previously mentioned, tissue signal attenuation in DWI 
that is observed with increasing b values, reflects tissue 
diffusivity and reduces the effect of tissue microcapillary 
perfusion. This signal attenuation can be measured quan-
titatively. The most common quantitative evaluation of 
DWI is ADC, which has been used for characterization of 
both normal and pathological tissues. ADC has been used in 
diagnosis, prognosis, and treatment monitoring in patients 
with tumors arising from various sites. However, ADC val-
ues are influenced by both tissue diffusivity and pseudor-
andom motion, which is caused by microcapillary perfu-
sion. The perfusion effect is difficult to eliminate. The IVIM 
technique estimates parametric values of those effects 
separately, measuring DWI across multiple b values and 
employing biexponential fitting.
The biexponential model best fits the description of signal 
intensity and b coefficient value correlation.
Si=Sfit[(1–Fp)e–biD+Fpe–biD*]
Si – the measured signal intensity with diffusion weighting b
Sfit – signal intensity for b=0
Fp – pseudodiffusion fraction
D – the true diffusion coefficient
D* – pseudodiffusion coefficient
In this model, the first exponent describes signal attenua-
tion caused by true diffusion, and the second one describes 
signal attenuation caused by pseudodiffusion.
Type of sequence
Attenuation of the 
signal by adipose 
tissue 
Plane TR (time repetition)TE (time echo)





Images T2 dependent TSE
(Turbin Spin Echo) Yes Transversal
TR=4480 ms
TE=68 ms 3.0/1.0 mm 256×256
Images T2 dependent TSE
(Turbin Spin Echo) No Transversal 
TR=313 ms
TE=92 ms 3.0/1.0 mm 256×256
Images DWI EPI (Spin Echo)
b 0, 50, 150, 300, 500, 750, 1000, 1200 Yes Transversal
TR=3200 ms
TE=88 ms 4.0/1.2 mm 192×192
Dynamic Examination Images T1 
dependent GRE (Gradient Echo) Yes Transversal
TR=5.5 ms
TE=2.4mm 1.1/03 mm 256×256
Images T1 dependent CM Yes Transversal TR=585 msTE=9.2 ms 3.0/1.0 mm 512×512
Table 1. Parameters of MR algorithms together with DWI-MR.
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The perfusion fraction is a quantitative estimate of the 
contribution of microperfusion to the signal loss in DWI.
To determine the parameters, i.e., Sfit, Fp, D, and D*, 
MatLab programming tools were used, including an option 
of function fitting with the defined characteristics to the 
values determined empirically. However, since the fitting 
of all parameters in this equation (with four unknown 
variables) can be problematic, especially in the case of low 
perfusion or with small number of measurements, for vari-
ous b values (most often used for calculation of the per-
fusion fraction) an algorithm was used that was based on 
monoexponential fitting of the signal attenuation curve. 
Similar algorithm was used for higher b values (typically b 
>100 s/mm2), assuming that, above the determined b value, 
signal attenuation is affected by the extracapillary factor 
(true diffusion) only.
Si=Sexpe–biD
Sexp has been extrapolated for b=0 s/mm2 value of the sig-
nal, determined by fitting of the exponential curve for b 
>100 s/mm2.
Sexp estimation enables to assess perfusion fraction (Fp) 
according to the model
3Fp=S0–Sexp/S0
S0 – signal value for b=0 s/mm2
Results
The true diffusion coefficient was calculated as a fit of a 
monoexponential curve to the measured signal values of b 
>300 s/mm2.
Sx=Sexte–bxD
Sx – signal intensity for b >300 s/mm2
bx – coefficient b value
D – true diffusion coefficient
In this particular model, a simultaneous calculation of two 
unknown values, Sext and D, was possible (as presented in 
Table 2).
The mean, median, maximal, and minimal D values in both 
groups of lymph nodes were comparable.
These true diffusion coefficient values were similar in 
both groups, as confirmed by the Mann-Whitney U test 
(p=0.5220).
The perfusion fraction, which indicates the percentage of 
perfusion in the decrease of signal intensity, was calculated 
from DWI images, with an increase of b values according to 
the following equation: 
in which: 
So – signal intensity for b=0 s/mm2 (Table 3).
Based on the Mann-Whitney U test, the mean values of per-
fusion fraction (Fp) were similar in both groups of lymph 
nodes (p=0.2940).
The pseudodiffusion coefficient was calculated as a biexpo-
nential curve fit, using the following model:
in which: 
Sx – signal intensity for b >0 s/mm2
So – signal intensity for b=s/mm2
D – true diffusion
D* – pseudodiffusion
bx – b coefficient value
Fp – perfusion fraction












Metastatic 0.652 0.640 0.310 1.21 ± 0.19
Nonmetastatic 0.686 0.650 0.320 1.13 ± 0.20




Mean Median Minimum Maximum
Metastatic 18.1 14.7 3.4 53.6 ± 10.7
Nonmetastatic 21.8 19.3 5.9 61 ± 13.6
Table 3. Perfusion fraction (Fp) values in both groups of lymph nodes.
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As in the case of previously calculated parameters (D and 
Fp), the mean values of pseudodiffusion coefficients, in 
both groups of lymph nodes, were similar (based on the 
Mann-Whitney U test; p=0.3046)
Discussion
Neoangiogenesis and increased perfusion are characteris-
tic features of malignant tumors. It is interesting, whether 
these features could be used for differentiation between 
metastatic and non-metastatic lymph nodes.
True diffusion of water particles in the extravascular/
extracellular compartment, together with blood movement 
in the capillary vessels (that mimics diffusion), influence 
diffusion spectra [1,11,12].
The IVIM model has been implemented for differentiation 
between malignant and benign lesions, based on their cel-
lular density (D), taking into consideration perfusion (Fp, 
D*) as a marker of tumor vascularization [7].
DWI spectra obtained with low b values are primarily 
affected by perfusion, although a specific b (s/mm2) thresh-
old value has not been commonly accepted yet.
The b coefficient value of 200 s/mm2 has been accepted 
by most authors as a threshold value for pseudodiffusion 
[1,5,6,11,13]. Most studies, that reported the clinical use of 
IVIM parameters, investigated tumors of the brain, liver, 
breast, and prostate. However, studies exploring the IVIM 
model for head and neck cancer are sparse.
Recently, Sumi et al. reported the results of an analysis of 
123 head and neck tumors in 118 patients. Using the IVIM 
model, 6 various tumor types, including squamous carci-
noma, lymphoma, neuroma, Warthin tumor, adenocarci-
noma, and benign neck tumors, were described. The high-
est, moderate and lowest pseudodiffusion parameters were 
observed in malignant salivary gland tumors, squamous 
cell carcinoma, and lymphoma, respectively [14].
According to those authors, various IVIM spectra were 
dependent on different histological tumor structures, and 
most importantly, on the quantity of extracellular tissue 
stroma. For instance, malignant tumors originating from 
the salivary glands consisted of nests of cancer cells with 
abundant blood vessels. Various quantities of stroma tis-
sue with neoangiogenesis was a typical feature of the squa-
mous cell cancer. In contrast, lymphomas consisted most-
ly of intensively dividing, tightly packed, neoplastic cells 
without much stroma between them.
The IVIM model, as a tool for assessing treatment results in 
patients with HNC, has been recently reported by Hauser. 
For primary and metastatic tumors with a high perfusion 
fraction or a high ADC value on initial examination, treat-
ment responses were significantly worse. High initial ADC 
values usually reflected necrosis that might explain poor 
responses to radiotherapy or chemotherapy [10,15].
Lymph nodes with increased vascularization (i.e. increased 
perfusion fraction) were observed in patients with HNC 
who failed treatment [10].
The true diffusion coefficient was similar in the case of 
persistent neck nodes (D=0.88–0.97×10–3 mm2/s) and in 
the cured patients (D=0.64–0.88×10–3mm2/s) (p=0.30). 
Based on the IVIM model, primary pharyngeal tumors and 
metastatic lymph nodes were compared by Lu et al. In that 
study, significantly lower values of perfusion fraction and 
higher true diffusion coefficient values were observed in 
metastatic nodes, in comparison to the primary pharyngeal 
tumors [16].
Also, using the IVIM model, some malignant tumors (squa-
mous cell carcinoma, adeno-cystic carcinoma, and pleo-
morphic adenocarcinoma) and benign tumors (mixt tumor, 
myoepithelial tumor, and vascular malformation) were 
compared by Sakamoto et al. According to their report, 
significantly lower values of ADC and true diffusion coef-
ficients as well as higher values of pseudodiffusion coef-
ficients were observed in malignant tumors. However, 
the perfusion fraction was similar in both groups of 
tumors [18].
In summary, in this study, the values of D, D*, and Fp in 
all lymph nodes were calculated and compared. These 
parameters did not differ significantly between metastatic 
and non-metastatic groups of lymph nodes. In addition, the 
mean values of true diffusion coefficient (p=05220), perfu-
sion fraction (p=0.2940), and pseudodiffusion (p=0.3046) 
were comparable in both groups. It should be noted that 
the values of true diffusion coefficient and perfusion frac-
tion, calculated in our study for the metastatic nodes, were 
comparable to those reported by Hauser and Lu [10,16].
Conclusions
Pseudodiffusion, perfusion fraction and true diffusion 
should not be used for differentiation between metastatic 











Metastatic 11.9 7.8 3.2 45.1 ± 10.2
Nonmetastatic 15.5 9.8 3.6 44.3 ± 12.7
Table 4. Pseudodiffusion values (D*) in both groups of lymph nodes.
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